Sign Up to like & get recommendations! 1
Published in 2020 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2020.0652
Abstract: Importance Left ventricular (LV) thrombi can arise in patients with ischemic and nonischemic cardiomyopathies. Anticoagulation is thought to reduce the risk of stroke or systemic embolism (SSE), but there are no high-quality data on the… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2020.4306
Abstract: Importance Paralympic medicine is a newly adopted term to describe the varied health care issues associated with athletes in the Paralympics. Scarce scientific data, however, are currently available describing the cardiac remodeling in Paralympic athletes.… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2023.0845
Abstract: Importance Left ventricular conduction disease predicts heart failure and death, and the only strategies to mitigate its effects involve implantation of a permanent pacemaker. There are currently no proven preventive strategies for this common condition.… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2018.1456
Abstract: Key Points Question What is the variability in left ventricular ejection fraction (LVEF) as measured by different cardiac imaging modalities? Findings In this multicenter diagnostic study of 2032 patients with coronary artery disease and LVEF… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.36830
Abstract: Key Points Question What proportion of patients with left ventricular dysfunction identified during hospitalization for acute myocardial infarction have follow-up assessment of left ventricular ejection fraction (LVEF)? Findings In this cohort study of 501 patients,… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Advanced Science"
DOI: 10.1002/advs.202201291
Abstract: The left ventricular assist device (LVAD) is often used in the treatment of heart failure. However, 4% to 9% implanted LVAD will have thrombosis problem in one year, which is fatal to the patient's life.… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Brain and Behavior"
DOI: 10.1002/brb3.1643
Abstract: Few studies of the effect of cardiac abnormalities on acute intracerebral hemorrhage (ICH) outcomes have been published. We sought to determine whether the left ventricular ejection fraction (LVEF) is associated with the functional outcome and… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2922
Abstract: BRAF and MEKis have revolutionized the management of BRAFV600‐mutated melanoma patients. Left ventricular ejection fraction decrease (LVEF‐D) related to these treatments has not been thoroughly evaluated to date. The main objective of this study was… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26720
Abstract: Transcatheter aortic valve implantation (TAVI) and balloon aortic valvuloplasty (BAV) are now well established percutaneous procedures. These procedures almost always require bursts of rapid ventricular pacing to temporarily reduce cardiac output to facilitate the procedure,… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27329
Abstract: Mechanical cardiovascular support devices are now widely used both in the setting of cardiogenic shock as well as during high risk cardiac catheterization procedures. We report a case of a young female patient who presented… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27347
Abstract: To assess the impact of low flow with and without preserved left ventricular ejection fraction (LVEF) on outcomes after transcatheter aortic valve replacement (TAVR). read more here.